User profiles for Amelie Franken

Amelie Franken

KU Leuven - VIB CCB
Verified email at kuleuven.be
Cited by 486

[HTML][HTML] A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

…, S Verbandt, P Busschaert, A Bassez, A Franken… - Cell research, 2020 - nature.com
The stromal compartment of the tumor microenvironment consists of a heterogeneous set of
tissue-resident and tumor-infiltrating cells, which are profoundly moulded by cancer cells. An …

[HTML][HTML] Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection

…, K De Vusser, M Eloudzeri, A Franken… - Nature …, 2023 - nature.com
Rejection remains the main cause of premature graft loss after kidney transplantation, despite
the use of potent immunosuppression. This highlights the need to better understand the …

[HTML][HTML] Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis

A Franken, P Van Mol, S Vanmassenhove… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitor (ICI)-related pneumonitis is the most frequent fatal
immune-related adverse event associated with programmed cell death protein-1/…

[PDF][PDF] CD4+ T cell activation distinguishes response to anti-PD-L1+ anti-CTLA4 therapy from anti-PD-L1 monotherapy

A Franken, M Bila, A Mechels, S Kint, J Van Dessel… - Immunity, 2024 - cell.com
Cancer patients often receive a combination of antibodies targeting programmed death-ligand
1 (PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA4). We conducted a window-of-…

Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma

M Bila, A Franken, J Van Dessel, M Garip… - Oral Oncology, 2024 - Elsevier
Objectives Immune checkpoint inhibitors (ICI) have introduced a new era in the treatment of
recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Optimal …

Neoadjuvant durvalumab and tremelimumab in resectable locally advanced SCC of the oral cavity: DUTRELASCO study.

M Bila, A Franken, J Van Dessel, S Verbandt… - 2023 - ascopubs.org
6081 Background: Promising rates of response to ICI have been observed in patients with
OSCC. This is phase I/II study with focus on biological changes observed in sequential tissue …

A pan-cancer single-cell tumor micro-environment atlas predictive of immunotherapy response

…, S Vanmassenhove, E Donders, P Van Mol, A Franken… - Cancer Research, 2023 - AACR
The tumor microenvironment (TME) shapes response to immune checkpoint blockade (ICB).
Several pan-cancer single-cell RNA-sequencing (scRNA-seq) analyses have reported how …

Single-Cell Omics to Reveal Mechanisms of Response to Immunotherapy in Head and Neck CancerSingle-Cell Omics to Reveal Mechanisms of Response to …

A Franken - 2024 - lirias.kuleuven.be
The body's natural defense system is designed to recognize and eliminate altered or foreign
cells, including cancerous ones. However, cancer cells can occasionally evade this system, …

Facing the future: a blueprint for a resilient and equitable society: connecting the functional building blocks

…, S Debeaussaert, T Dubois, A Franken… - Transdisciplinary …, 2018 - ingentaconnect.com
Contemporary society is plagued by a number of issues and inconsistencies on both an
environmental and a socio-economic level. Reliance on bank loans forces debtors to seek …

Changes in the epidemiology of childhood invasive pneumococcal disease in Belgium after switching from 13-valent to 10-valent pneumococcal conjugate vaccine

…, W Peetermans, L Laenen, A Franken… - 29th ECCMID, Date …, 2019 - lirias.kuleuven.be
Conclusions: We report the real-world impact of a change from PCV1 3 to PCVI 0. Two to
three year after the vaccine switch, a re-emergence of ST1 9A IPD in children< 2 years is …